Inhaled corticosteroids may lower mortality risk in COPD patients

04/20/2011 | HealthDay News

Patients age 65 and older with chronic obstructive pulmonary disease who were admitted for pneumonia and did not receive inhaled corticosteroids had an almost 25% increased death risk compared with counterparts who were given the medication, according to a study in the American Journal of Respiratory and Critical Care Medicine. "Our study would suggest that inhaled corticosteroid use may confer a survival benefit to these patients and may be employed when there are not contraindications," said lead researcher Dr. Eric Mortensen.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX